Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 3
Submit an article Journal homepage
140
Views
10
CrossRef citations to date
0
Altmetric
Original Articles Clinical

Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma

Kristie A. Blum Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USACorrespondence[email protected]
,
Mehdi Hamadani Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
,
Gary S. Phillips Biostatical Core, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
,
Gerard Lozanski Department of Pathology, The Ohio State University, Columbus, OH, USA
,
Amy J. Johnson Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
,
David M. Lucas Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
,
Lisa L. Smith Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
,
Robert Baiocchi Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
,
Thomas S. Lin Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
,
Pierluigi Porcu Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
,
Steven M. Devine Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
&
John C. Byrd Division of Hematology–Oncology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
 show all
Pages 349-356 | Received 25 Nov 2008, Accepted 04 Jan 2009, Published online: 01 Jul 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jeremy S. Abramson, Ronald W. Takvorian, David C. Fisher, Yang Feng, Eric D. Jacobsen, Jennifer R. Brown, Jeffrey A. Barnes, Donna S. Neuberg & Ephraim P. Hochberg. (2013) Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study. Leukemia & Lymphoma 54:9, pages 1915-1920.
Read now
Götz Ulrich Grigoleit, Markus Kapp, Sen Mui Tan, Christian Unzicker, Hermann Einsele, Stephan Mielke, Max S. Topp & Gernot Stuhler. (2009) Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series. Leukemia & Lymphoma 50:12, pages 2071-2074.
Read now
Kristie A. Blum, Mehdi Hamadani, Gary S. Phillips, Gerard Lozanski, Amy J. Johnson, David M. Lucas, Lisa L. Smith, Robert Baiocchi, Thomas S. Lin, Pierluigi Porcu, Steven M. Devine & John C. Byrd. (2009) Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma 50:7, pages 1232-1234.
Read now
Chadi Nabhan. (2009) Clofarabine in relapsed lymphoma: what is the optimal dose?. Leukemia & Lymphoma 50:7, pages 1230-1231.
Read now

Articles from other publishers (6)

William B. Parker & Varsha Gandhi. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia 261 286 .
Ann Colosia, Annete Njue, Peter C. Trask, Robert Olivares, Shahnaz Khan, Adeline Abbe, Rachel Police, Jianmin Wang, Rodrigo Ruiz-Soto, James A. Kaye & Farrukh Awan. (2014) Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review. Clinical Lymphoma Myeloma and Leukemia 14:5, pages 343-355.e6.
Crossref
Shivani Srivastava, David Jones, Lisa L. Wood, Jennifer E. Schwartz, Robert P. NelsonJr.Jr., Rafat Abonour, Angie Secrest, Elizabeth Cox, Jay Baute, Cheryl Sullivan, Kathleen Kane, Michael J. Robertson & Sherif S. Farag. (2011) A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation 17:7, pages 987-994.
Crossref
Chadi Nabhan, Nancy Davis, Jacob D. Bitran, Angel Galvez, Walter Fried, Kathy Tolzien, Susan Foss, Wendy M. Dewey & Parameswaran Venugopal. (2010) Efficacy and safety of clofarabine in relapsed and/or refractory non‐hodgkin lymphoma, including rituximab‐refractory patients. Cancer 117:7, pages 1490-1497.
Crossref
Elliott D. Crouser, Gerard Lozanski, Charity C. Fox, David W. Hauswirth, Rekha Raveendran & Mark W. Julian. (2010) The CD4 + Lymphopenic Sarcoidosis Phenotype Is Highly Responsive to Anti-Tumor Necrosis Factor-α Therapy. Chest 137:6, pages 1432-1435.
Crossref
Sima Jeha. (2009) Recent Progress in the Treatment of Acute Lymphoblastic Leukemia: Clofarabine. Hematology/Oncology Clinics of North America 23:5, pages 1137-1144.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.